Our previous study aligns with a later study indicating that A1AG1 levels were markedly increased in non-responders with squamous cell carcinoma (SCC) but not in ADC receiving carboplatin and paclitaxel [22]. The gene discussed is ORM1; the disease is squamous cell carcinoma.